New injection device in UK delivers optimum treatment dose to Hep C patients
Cinnamon Girl said
Oct 7, 2013
Saturday, October 5, 2013. A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
The device has been specially designed to maintain dosing flexibility, across five dosage strengths (50 mcg/0.5 mL, 80 mcg/0.5 mL, 100 mcg/0.5 mL, 120 mcg/0.5 mL and 150 mcg/0.5 mL) helping nurses and patients to deliver the optimal dose and help maximise patient outcomes.
Clearclick will replace the existing Redipen and offer a number of additional features such as clearer markings and audible feedback to confirm that the proper dose has been injected as well as an ergonomic design and needle shield to help patients safely and accurately administer a dose.
Saturday, October 5, 2013. A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
The device has been specially designed to maintain dosing flexibility, across five dosage strengths (50 mcg/0.5 mL, 80 mcg/0.5 mL, 100 mcg/0.5 mL, 120 mcg/0.5 mL and 150 mcg/0.5 mL) helping nurses and patients to deliver the optimal dose and help maximise patient outcomes.
Clearclick will replace the existing Redipen and offer a number of additional features such as clearer markings and audible feedback to confirm that the proper dose has been injected as well as an ergonomic design and needle shield to help patients safely and accurately administer a dose.
http://hcvadvocate.blogspot.ca/2013/10/uk-new-injection-device-delivers.html